The completed safety study by July and the in vitro psoriasis skin study results by mid-May published in a medical journal around that time. That will validate the intellectual property and increase interest from manufacturers & distributors. Even when developing a product that doesn't require FDA approval it takes time, proper filings, accurate results to prove the product is worthy of taking to market.